Compare Badger Meter Inc (BMI) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Badger Meter Inc vs Moderna, Inc. — how do they compare? Badger Meter Inc trades at $133.4 (market cap $3.93B), while Moderna, Inc. trades at $61.5 (market cap $24.18B). The key difference: Moderna, Inc. is far larger — about 6.2× Badger Meter Inc's market cap, and Badger Meter Inc pays a 1.18% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| BMI | MRNA | |
|---|---|---|
Market Cap | $3.93B | $24.18B |
Sector | Technology | Health |
52-Week High | $193.09 | $81.80 |
52-Week Low | $113.41 | $22.36 |
Enterprise Value | $3.84B | $20.33B |
Dividend Yield | 1.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Moderna (MRNA) trades at $59.81, up 1.08% today, with a bullish technical signal from moving averages and recent FDA approval for its mRNA flu vaccine mFLUSIVA. Despite beating Q2 2026 EPS estimates, revenue has declined from pandemic peaks, with a net income margin of -142.58% in 2026. The stock faces resistance near $61-$63, while support lies at $56-$59.
Outlook remains mixed; pipeline advancements in flu, Ebola, and oncology offer growth potential, but persistent losses and high valuation ratios pose risks. Analyst consensus is cautious with a $54.33 price target below current levels, reflecting concerns over profitability amid transitioning business focus.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Badger Meter Inc
Badger Meter provides industry-leading water management solutions. Its smart measurement hardware and software analytics help water utilities and industrial customers optimize operations and conserve natural resources.
Read more on BMI →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
